HIV Research for Prevention Conference combining AIDS Vaccine & Microbicides

本赠款申请的目的是申请资金，以部分支持规划，组织和主办艾滋病毒预防研究2014年：疫苗，杀微生物剂和基于ARV的预防科学会议（R4 P2014），一个国际会议。R4 P2014将是世界上第一个也是唯一一个致力于生物医学艾滋病预防研究的科学会议。其主要目标是帮助创造机会，在生物医学预防研究中进行跨学科互动;随着新的艾滋病毒预防方案的制定，扩大对交叉问题的讨论，并加强国际团体之间的协调和沟通。在过去几年中，寻求有效的生物医学艾滋病毒预防办法的进展比该流行病开始以来的任何时候都要快。最近在疫苗、基于抗逆转录病毒药物的杀微生物剂、预防前预防、预防治疗和其他预防技术方面的突破为减少全球流行病的影响创造了新的机会。这一进展也为科学辩论带来了机会，并在我们继续推进艾滋病毒生物医学预防研究的过程中提出了新的挑战。最重要的是，这些进展告诉我们，有效的艾滋病毒预防将需要采取综合办法。为了反映这一新方法，我们提议在2014年举办一次新的、更广泛的预防研究会议，即“艾滋病毒预防研究”。第一次两年期会议将于2014年10月28日至31日在南非开普敦的开普敦国际会议中心举行。这次国际会议将汇集研究人员，倡导者，临床医生，政策制定者，私营部门合作伙伴和公共卫生专家，介绍，讨论和辩论基于ARV的预防，疫苗和艾滋病毒预防相关领域的最新研究。它将建立在过去两年一次的杀微生物剂和每年一次的艾滋病疫苗会议的成功基础上，并与之联系起来。会议将推动更大的协调、相互促进和加强合作。它还将提供一个论坛， 它将解决交叉问题，强调综合预防的重要性，并将打破不同预防技术之间的任何现有研究孤岛。因此，R4 P 2014将对独特预防领域的科学研究进步产生重大影响，有可能在预防艾滋病毒感染方面取得重大进展。该会议将吸引1，200 - 1，500名艾滋病毒预防社区成员，并将为早期职业和中低收入国家（LMIC）科学家提供200个全额和100个部分奖学金以及补贴注册率。在会议上提出的信息将被传播，让世界各地的所有人都能免费参加。同行评审的摘要将在线发表在一份开放获取期刊上，海报将作为电子海报在线提供。所有会议都将通过网播提供，包括在会议网站上免费下载幻灯片和音频。

DESCRIPTION (provided by applicant): The purpose of this grant application is to request funds to partially support planning, organizing and hosting HIV Research for Prevention 2014: Vaccine, Microbicide and ARV-based Prevention Science Conference (R4P2014), an international conference. R4P2014 will be the world's first and only scientific meeting dedicated to biomedical HIV prevention research. Its primary goals are to help create opportunities for trans-disciplinary interactions in biomedical prevention research; expand discussions of crosscutting issues as new HIV prevention options are developed, and increase coordination and communication among international groups. The pursuit of effective biomedical HIV prevention options has progressed further and faster in the last few years than at any time since the epidemic began. Recent breakthroughs in vaccines, ARV-based microbicides, PrEP, treatment for prevention and other prevention technologies create new opportunities to reduce the impact of the global epidemic. This progress also brings opportunity for scientific debate and creates new challenges as we continue to move HIV biomedical prevention research forward. Most importantly, these advances teach us that effective HIV prevention will require a combination of approaches. Reflective of this new approach, we propose a new, broader prevention research conference for 2014, HIV Research for Prevention. This first bi-annual meeting will take place 28-31 October 2014 at the Cape Town International Conference Centre in Cape Town, South Africa. This international conference will bring together researchers, advocates, clinicians, policy makers, private sector partners and public health experts to present, discuss, and debate the latest research in ARV-based prevention, vaccines and related areas of HIV prevention. It will build on and link to the successes of the past bi-annual Microbicide and annual AIDS Vaccine conferences it will replace. The conference will drive greater coordination, cross-fertilization and increased collaboration. It will also provide a forum to address cross-cutting issues, emphasizing the importance of combination prevention, and it will break down any existing research siloes between different prevention technologies. R4P 2014 will therefore have a significant impact on the advancement of scientific research in unique prevention areas with the potential to make significant progress in the prevention of HIV infection. The conference will attract between 1,200-1,500 members of the HIV prevention community and will provide 200 full and 100 partial scholarships as well as subsidized registration rates for early-career and lower-middle income country (LMIC) scientists. Information presented at the conference will be disseminated to give free, worldwide access to all who are unable to attend in person. Peer-reviewed abstracts will be published online in an open access journal, and posters will be available online as e-posters. All sessions will be available as webcasts, including free downloads of slides and audio on the conference web site.